Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Meeting ReportEconomic or policy analysis

An economic evaluation of prescription drug costs in a deprescribing initiative in a Skilled Nursing Facility System

Martha Wojtowycz, Christopher Morley, Alyssa Indelicato and Sharon Brangman
The Annals of Family Medicine November 2023, 21 (Supplement 3) 5450; DOI: https://doi.org/10.1370/afm.22.s1.5450
Martha Wojtowycz
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Morley
PhD, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alyssa Indelicato
BA, MPH In Progress
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon Brangman
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

Context: Polypharmacy increases health care system costs.

Objective: Does a deprescribing protocol reduce the number and cost of prescriptions filled by medication class in two skilled nursing facilities (SNFs).

Study Design and Analysis: Retrospective, longitudinal pre/post evaluation. Comparison of the number and cost of prescriptions by medical class in the pre-intervention period (2017-2019) with the post-intervention period (2020-2021). Prescription drug prices were adjusted to reflect the average prescription drug price increase over time.

Setting or Dataset: Prescription level data received from the medication supplier to the SNFs, which included prescription drug category (anti-anxiety agents, antibiotics, anticoagulants, antidepressants, antipsychotics, diuretics, hypnotics, opioids), drug name, dose, drug price, insurance company, name brand or generic, and a system generated identifier that allowed for aggregation of prescriptions by patient.

Population Studied: Patients at two SNFs.

Intervention/Instrument: Deprescribing effort in two SNFs that included clinician education, protocol development and chart reviews.

Outcome Measures: Number and proportion of prescriptions by drug category, and number of patients with a prescription by drug category, in the pre- and post-intervention period. Descriptive statistics on prescription drug costs and total expenditures on prescription drugs by drug category, pre- and post-intervention.

Results: There were 50,194 prescriptions and 2,839 patients in the pre-intervention period, and 48,822 prescriptions and 2,580 patients in the post-intervention period. There was a statistically significant reduction in the number and proportion of prescriptions in the post-intervention period for anti-anxiety agents, antipsychotics, diuretics, and opioids. The number and proportion of prescriptions for anticoagulants and antidepressants was significantly higher in the post-intervention period. There was a significant increase in the mean cost of prescription drugs in the anticoagulant and antipsychotic drugs, explained by the prescribing of newer brand name drugs. Postintervention total expenditures were lower on anti-anxiety agents and opioids, and higher for anticoagulants and antipsychotics. Overall expenditures were higher post-intervention due to significantly higher expenditures for anticoagulants and antipsychotics.

Conclusions: Cost savings in some categories were offset by newer, more expensive drugs.

  • © 2023 Annals of Family Medicine, Inc.
Previous
Back to top

In this issue

The Annals of Family Medicine: 21 (Supplement 3)
The Annals of Family Medicine: 21 (Supplement 3)
Vol. 21, Issue Supplement 3
1 Nov 2023
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An economic evaluation of prescription drug costs in a deprescribing initiative in a Skilled Nursing Facility System
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
An economic evaluation of prescription drug costs in a deprescribing initiative in a Skilled Nursing Facility System
Martha Wojtowycz, Christopher Morley, Alyssa Indelicato, Sharon Brangman
The Annals of Family Medicine Nov 2023, 21 (Supplement 3) 5450; DOI: 10.1370/afm.22.s1.5450

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
An economic evaluation of prescription drug costs in a deprescribing initiative in a Skilled Nursing Facility System
Martha Wojtowycz, Christopher Morley, Alyssa Indelicato, Sharon Brangman
The Annals of Family Medicine Nov 2023, 21 (Supplement 3) 5450; DOI: 10.1370/afm.22.s1.5450
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Economic analysis of virtual Medical Legal Partnership model
  • Saving money by integrating physiotherapists in the emergency department: Mission possible?
  • Practice patterns of Ontario physicians working in 'boutique' medical clinics
Show more Economic or policy analysis

Similar Articles

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine